3-吗啉-4-基丙酸

3-Morpholinopropanoic acid

1,2-二棕榈酰基-sn-甘油-3-(胞苷二磷酸)(铵盐)

1,2-dipalmitoyl-sn-glycero-3-(cytidine diphosphate) (ammonium salt)

>99.9%

MEK抑制剂II

MEK Inhibitor II

四（戊硫基）四硫富瓦烯

TPT-TTF

(4-(2-((叔丁氧羰基)(甲基)氨基)乙基)苯基)硼酸, 98%

4-[2-(N-Boc-N-Methyl)aminoethyl]phenylboronic acid

3-脱氧尿苷, 98%

1-((2R,3R,5S)-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

(6-氯吡啶-3-基)(环丙基)甲胺, 98%

(6-Chloropyridin-3-yl)(cyclopropyl)methanamine

CHES缓冲液, 0.5M,pH10.0

CHES Buffer

(R)-(3-甲基-1-氧代丁-2-基)氨基甲酸叔丁酯, 98%

(R)-tert-Butyl (3-methyl-1-oxobutan-2-yl)carbamate

(R)-2-氨基-2-(4-溴-2-氯苯基)乙烷-1-醇, 98%

(R)-2-amino-2-(4-bromo-2-chlorophenyl)ethan-1-ol

(R)-5-benzyl-7-(pyrrolidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine,

(R)-5-benzyl-7-(pyrrolidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine

马尿酰精氨酸, ≥99% (TLC)

Hippuryl-Arg

(S)-1-(5-氯-2-氟苯基)乙胺盐酸盐, 99%

(S)-1-(5-Chloro-2-fluorophenyl)ethanamine hydrochloride

RPMI 1640 培养基，含 L-谷氨酰胺,

RPMI-1640 Medium, with L-glutamine

N-[6-[(7-硝基-2-1,3-苯并恶二唑-4-基)氨基]己酰基]-鞘氨醇

N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sphinganine

>99.9%

(S)-2-氨基-4-((三氟甲基)硫代)丁酸, 98%

(S)-2-Amino-4-((trifluoromethyl)thio)butanoic acid

(S)-4-苄基-3-苯基哌嗪-2-酮, 98%

(S)-4-Benzyl-3-phenylpiperazin-2-one

1,1'-Biphenyl, 3,3',5,5'-tetraiodo-2,2',4,4',6,6'-hexamethyl-, 99%

1,1'-Biphenyl, 3,3',5,5'-tetraiodo-2,2',4,4',6,6'-hexamethyl-

1,3-二苄基哌嗪, 98%

N-1-benzyl-3-benzyl-piperazine

(3R,4S)-3-氟-4-羟基哌啶-1-羧酸叔丁酯, 98%

(3R,4S)-tert-Butyl 3-fluoro-4-hydroxypiperidine-1-carboxylate